跳至主要内容
临床试验/IRCT201309125381N8
IRCT201309125381N8已完成2 期

Effect of tranexamic acid on blood loss after coronary artery bypass grafting in patients treated with clopidogrel

Vice-chancellor of Research Babol University Of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
36 years 至 75 years(—)
性别
Female

入选标准

  • patients undergoing on-pump CABG who received clopidogrel with their last ingestion less than5 days preoperatively.
  • Exclusion criteria: previous cardiac surgery; hematocrit less than 33%; platelet count less than 100,000/mL; or allergy to tranexamic acid; renal failure(cr>2), hepatic failure; history of bleeding diasthesis; abnormal coagulation test; previous cardiac surgerry.

排除标准

  • 未提供

研究者

发起方
Vice-chancellor of Research Babol University Of Medical Sciences

相似试验